Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Abstract
Key Points: Limited-stage diffuse large B-cell lymphoma has good outcomes with CHOP followed by radiotherapy but has a pattern of continuous relapses. Adding radioimmunotherapy consolidation results in outcomes that are at least as good as with rituximab added to CHOP and radiotherapy.

This publication has 26 references indexed in Scilit: